Deferasirox (Compound)

Synonyms:Deferasirox, 201530-41-8, Exjade, ICL 670, ICL670A, ICL-670A, ICL 670A, ICL670, ICL-670, Deferasiroxum, Deferasiroxum [INN-Latin], Jadenu, 4-[3,5-Bis(2-hydroxyphenyl)-1,2,4-triazol-1-yl]benzoic acid, Osveral, Jadenu Sprinkle, 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid, 4-(3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl)benzoic acid, CGP-72670, Deferasirox (Exjade), CHEBI:49005, 1044764-54-6, V8G4MOF2V9, DTXSID1048596, Benzoic acid, 4-[3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]-, NCGC00181754-01, Benzoic acid, 4-(3,5-bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl)-, DTXCID1028522, 4-[bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid, 4-{3,5-bis[(1E)-6-oxocyclohexa-2,4-dien-1-ylidene]-1,2,4-triazolidin-1-yl}benzoic acid, SMR002544689, CAS-201530-41-8, UNII-V8G4MOF2V9, Deferasirox [USAN:INN:JAN], HSDB 7844, 4-(3,5-Bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl)benzoic acid, 4-[3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid, Deferasirox [INN], Exjade (TN), Jadenu (TN), Deferasirox, ICL670, DEFERASIROX [MI], DEFERASIROX [JAN], DEFERASIROX [HSDB], DEFERASIROX [USAN], DEFERASIROX [VANDF], 4-[(3Z,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid, DEFERASIROX [MART.], SCHEMBL61756, SCHEMBL62042, DEFERASIROX [USP-RS], DEFERASIROX [WHO-DD], MLS003915634, MLS006010080, Deferasirox (JAN/USAN/INN), DEFERASIROX [EMA EPAR], CHEMBL550348, SCHEMBL1071867, 4-[3,5-bis(2-hydroxyphenyl), DEFERASIROX [ORANGE BOOK], DEFERASIROX [EP MONOGRAPH], HMS3655A04, BCP05341, EX-A4091, Tox21_112926, BDBM50088376, MFCD09751362, MFCD09951804, s1712, AKOS015855839, AKOS015902587, AKOS025312553, Tox21_112926_1, AC-8972, BCP9000594, CCG-268337, CS-0901, DB01609, KE-0220, SB18926, NCGC00263572-01, HY-17359, Deferasirox 100 microg/mL in Acetonitrile, D5905, FT-0601564, FT-0665569, SW219752-1, D03669, AB01565800_02, A814288, EN300-26907573, SR-01000931971, J-013060, Q5251502, SR-01000931971-2, F0001-2380, Z3041510169, 4-[3,5-Bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid, 4-(3,5-Bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl)benzoicacid, 4-((3E,5E)-3,5-bis(6-oxocyclohexa-2,4-dien-1-ylidene)-1,2,4-triazolidin-1-yl)benzoic acid, 4-[(3Z,5E)-3,5-Bis(6-Oxo-2,4-cyclohexadien-1-ylidene)-1,2,4-triazolidin-1-yl]benzoic acid, AldrichCPR, 4-[(3z,5e)-3,5-bis(6-oxocyclohexa-2,4-dien-1ylidene)-1,2,4-triazolidin-1-yl] benzoic acid, 4-[3,5-Bis(2-hydroxyphenyl)-1H-1,2,4-triazol-1-yl]benzoic acid; CGP-72670; ICL-670; ICL-670A, JBL
Pubchem:PUBCHEM:214348
Id:ab892c09-e7f2-5377-bfc8-a97b6b98317a
Description:nan

Analyze

Data Distillery
CFDE DD-Knowledge Graph

The CFDE Data Distillery Knowledge Graph contains entities and relationships across the CFDE. View Deferasirox's neighborhood in the knowledge graph.

Gene and Drug Landing Page Aggegrator
GDLPA Landing Pages Links

The Gene and Drug Landing Page Aggregator (GDLPA) finds links to primary and secondary source information from CFDE and other resources. Discover landing pages for Deferasirox.

Playbook Workflow Builder
Playbook Workflow Builder

The Playbook Workflow Builder helps you interactively construct workflows leveraging CFDE APIs without code. Start a new workflow with Deferasirox.

Results found

Linked to

DISPLAY PER PAGE
This repository is under review for potential modification in compliance with Administration directives.